935 hedge funds and large institutions have $31.9B invested in DexCom in 2025 Q2 according to their latest regulatory filings, with 123 funds opening new positions, 337 increasing their positions, 348 reducing their positions, and 105 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding in top 10

Funds holding in top 10:

more ownership

Funds ownership:

1% more funds holding

Funds holding: 928935 (+7)

3% less repeat investments, than reductions

Existing positions increased: 337 | Existing positions reduced: 348

6% less call options, than puts

Call options by funds: $490M | Put options by funds: $519M

Holders
935
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
8
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$490M
Puts
$519M
Net Calls
Net Calls Change

Top Buyers

1 +$267M
2 +$217M
3 +$198M
4
JP Morgan Chase
JP Morgan Chase
New York
+$158M
5
Federated Hermes
Federated Hermes
Pennsylvania
+$128M

Top Sellers

1 -$520M
2 -$132M
3 -$88.4M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$87.8M
5
UBS AM
UBS AM
Illinois
-$77.8M
Name Holding Trade Value Shares
Change
Change in
Stake
651
$308K
652
$306K
653
$304K
654
$303K
655
$300K
656
$300K
657
$298K
658
$297K
659
$296K
660
$295K
661
$294K
662
$290K
663
$288K
664
$286K
665
$281K
666
$281K
667
$280K
668
$280K
669
$279K
670
$278K
671
$273K
672
$269K
673
$268K
674
$268K
675
$267K